Gainesville, FL, United States of America

Stephan Jahn

This inventor holds 1 USPTO granted patent. Top assignee: University of Florida Research Foundation Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephan Jahn. Retrieved from https://idiyas.com/inventor/stephan-jahn-7l243gby

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Stephan Jahn and His Anticancer Invention.

Introduction

Stephan Jahn is an inventor associated with Gainesville, Florida, and the University of Florida Research Foundation Inc. His work includes an invention focused on potential treatments for cancer and other cell proliferative disorders.

Latest Patents

Jahn is credited with 1 patent, titled “Small Molecule Anticancer Agents, Combinations and Uses Thereof.” The invention describes methods for treating cell proliferative disorders and pharmaceutical compositions intended for those conditions, especially cancer.

Career Highlights

Jahn’s listed patent connects his inventive work with research at the University of Florida Research Foundation Inc. The patent’s subject matter centers on developing anticancer agents and exploring their use in treatment.

Collaborations

Jahn’s listed coworkers include Brian Keith Law and Ronald K. Castellano. Their names are associated with the research context provided for the invention.

Conclusion

Stephan Jahn’s patent reflects research into pharmaceutical approaches for cancer and other cell proliferative disorders, in association with the University of Florida Research Foundation Inc.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…